ABSTRACT Peripheral blood and bronchoalveolar lavage lymphocyte subpopulations have been evaluated in 14 patients with pulmonary sarcoidosis and eight normal subjects, monoclonal antibodies of the leu series being used. No significant alterations of T lymphocyte subpopulations were found in the peripheral blood of sarcoidosis patients. There was, however, a significantly greater proportion of T suppressor-cytotoxic cells (36.0 (SD 17-6%)) in the bronchoalveolar lavage fluid of patients than of normal subjects (15% (5.6%); p < 0.01), but a decrease in the proportion of T helper-inducer cells (51.1% (18%) v 79.3% (9%). These changes correlated with the duration of the disease but not with other clinical, radiological, physiological, or biochemical criteria. Patients were followed up for six to 20 months and five patients had a repeat bronchoalveolar lavage and lymphocyte subpopulation evaluation after three to 14 months. The initial pulmonary T lymphocyte subset proportions were not predictive of clinical, physiological, or radiological alterations during follow up. There was also no consistent pattern in the relationship between change in T subset proportions and change in clinical physiological, and radiological features in the five patients having a repeat lavage. Lymphocyte surface marker studies may indicate immunopathogenetic mechanisms in sarcoidosis but do not appear to be good predictors of clinical outcome.
Various alterations in immune responses fig 2) . In the lung, the proportion of T suppressor-cytotoxic cells was significantly greater and of T helper-inducer cells significantly smaller than in normal subjects (p < 0.01) (table 3). Within the patient group the variations in the T cell subpopulations were consider- (table 1) . This observation is supported by the data on repeat lavage in five patients (table  2) , though the small size of this group, together with the fact that some received steroids while others did not, prevents firm conclusions from being drawn from the data. It should be noted that the one patient (No 7) who showed dramatic clinical, radiological, and physiological improvement had minimal changes in the percentage of bronchoalveolar lavage lymphocytes and no change in the proportion of leu 3a+ and leu 2a+.
Discussion
Our findings of an increased percentage of lymphocytes in the bronchoalveolar lavage cells from patients with sarcoidosis are consistent with previously described data." 21 22 . The percentage of lymphocytes in the bronchoalveolar lavage did not correlate with any of the standard measures we made (table 1) , although patients with disease of over 20 months' duration tended not to have increased lymphocytes. This observtion should be interpreted with caution since numbers of patients were small and "duration" of disease is imprecise. We took "duration" to be the time between objective diagnosis or onset of symptoms that could reasonably be attributed to sarcoidosis (for example, arthralgia, erythema nodosum) and bronchoalveolar lavage. Clearly, for some patients this will result in an underestimate of disease duration.
In sarcoidosis, where disease activity may vary between different organs, the lymphocyte subpopulations in peripheral blood may differ significantly from those in, for example, the lung." Our data ( fig  2) would indicate that this is also true for T cell subpopulations. In accord with Ginns et a123 we found that the proportions of these subpopulations in peripheral blood were not significantly different from those of normal subjects. Hunninghake and Crystal,'' however, have reported a small increase in T suppressor-cytotoxic cells in peripheral blood. There were methodological differences since we used monoclonal antibodies of the leu series whereas they used the OK T series, our total T cell population was identified by monoclonal antibody leu la and theirs by sheep red cell rosetting, and our T cell subpopulations were determined on cells purified by adherence and theirs by rosetting. There may also have been differences in selection of patients since our patients were all primary referrals.
In the bronchoalveolar lavage cells we found different proportions of T cell subpopulations in patients with sarcoidosis and in normal subjects (table 3, fig 2) 
